Hongye (Eve) Mao

Hongye (Eve) Mao

Associate

Hongye (Eve) Mao

Associate

  • Overview

    Biography

    Hongye (Eve) Mao is a member of the firm’s Business Transactions Group and its Capital Markets + Securities team. Prior to joining Robinson+Cole, Eve participated in a research program at a New York law firm in a specialty practice group that represents Chinese companies doing business and/or listing their securities in the U.S., as well as U.S. companies with operations and activities in China. Her experience includes drafting Form S-1s and transactional documents for SEC registration, including SPAC IPOs; applying for Nasdaq tickers, Nasdaq application listings, and CUSIP numbers; and conducting research on SPAC precedents, SEC statements and related legal issues. Previously, Eve worked as a Legal Fellow of the Financial Frauds Bureau in the District Attorney’s Office of Manhattan County in New York.

    Eve has worked as a legal intern at a law firm in Shanghai, China, where she conducted legal research on civil procedures and labor law issues, reviewed employment and commercial contracts for compliance with Chinese contract law, labor law and cross-border payment regulations, drafted labor contracts and confidentiality agreements, and translated legal documents regarding dispute resolution, including judgments, contracts and evidence to be used in court.

    Eve also was an extern with Administrative Law Judges at the National Labor Relations Board in Washington, D.C. While there, she was responsible for conducting legal research on labor law issues from past NLRB decisions, preparing bench memoranda and drafting orders and opinions for the Chamber of Senior Judges.

  • Experience
    • Experience

      Experience

      • Represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Phoenix Motor Inc., a California-based company that designs, assembles, and integrates electric drive systems and light- and medium-duty electric vehicles. The firm’s Capital Markets + Securities Team advised Prime Number on the offering, with aggregate gross proceeds of $15.75M, announced on June 7, 2022.

  • NEWS + PRESS
    • News

      R+C in the News

      • June 10, 2022

        Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Phoenix Motor Inc.

        • » more info

          Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Phoenix Motor Inc.

          Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Phoenix Motor Inc., a California based company that designs, assembles, and integrates electric drive systems and light and medium duty electric vehicles, of 2.1 million shares of common stock at an offering price of $7.50 per share, for aggregate gross proceeds of $15.75 million. The shares began trading on the Nasdaq Capital Market under the ticker symbol “PEV” on June 8, 2022. On June 10, 2022, the Team attended the opening bell ceremony at Nasdaq MarketSite in Times Square to celebrate the listing of PEV common stock. The Team members advising Prime Number on the offering were Arila Zhou, Anna Wang, Eve Mao and Yang Xu. Read more.

      • March 17, 2022

        Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Meihua International Medical Technologies

        • » more info

          Capital Markets + Securities Team Pleased to Represent Prime Number Capital LLC in IPO of Meihua International Medical Technologies

          Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Prime Number Capital LLC, the lead underwriter in an initial public offering of Meihua International Medical Technologies (Nasdaq ticker symbol “MHUA”), a manufacturer and provider of disposable medical devices with operating subsidiaries in China. At the closing of the IPO on February 18, 2022, a total of 3,940,000 ordinary shares of MHUA, listed on Nasdaq Global Market, were sold at a public offering price of $10.00 per ordinary share (the "Ordinary Shares"), including 340,000 Ordinary Shares issued pursuant to the partial exercise of the underwriters' over-allotment option, for aggregate gross proceeds of $39.4 million before deducting underwriting discounts and commissions and offering expenses. The successful share sale makes MHUA the first China-based company to list in the U.S. since July 2021. The Team members advising on the offering were Arila Zhou, Mitchell Lampert, Anna Wang, Yang Xu and Eve Mao. Read more.

        • View article